Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ROACTEMRA vs ROFLUMILAST: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ROACTEMRA vs ROFLUMILAST: Safety Overview

Metric ROACTEMRA ROFLUMILAST
Total FAERS Reports 164 2,700
Deaths Reported 14 645
Death Rate 8.5% 23.9%
Hospitalizations 65 625
Average Patient Age 51.2 yrs 68.8 yrs
% Female Patients N/A 56.3%
FDA Approval Date N/A Apr 17, 2023
Manufacturer N/A Aurobindo Pharma Limited
Route N/A ORAL
Marketing Status N/A Prescription